DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Galanello R, Piga A, Forni GL et al.
Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major.
Haematologica 2006;
91: 1343-1351
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.